ITC's alignment with healthcare's a global trend it needs to deepen

ITC's shares gained 1.5% Thursday on the back of the company conducting clinical trials for developing a nasal spray for Covid-19 prevention. It plans to market the nasal spray under the Savlon brand once it gets all the requisite approvals. Investors cheered the move even though it is still early stage for the company.

via Economictimes